Uroselectivity: end of the road?
Wyllie
Michael G
MG
mike@urodoc.co.uk
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D016587:Antimutagenic Agents / Q000627:therapeutic use; D015195:Drug Design; D004345:Drug Industry / Q000639:trends; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D016587:Antimutagenic Agents